Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMNZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,052
Award facts
- Contract value 100% obligated
- $2,052.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $2,052.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense healthcare operations globally.
DMS Pharmaceutical Group supplies an extensive portfolio of pharmaceutical products and medical consumables to support military healthcare facilities, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and over-the-counter products. The company's IDC under PPV-G GEN V, designated as contract SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and extends through December 31, 2036, featuring a 30-month base period with three 30-month option periods. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated substantial performance across multiple delivery orders and purchase orders, positioning the company as a key regional prime vendor contractor supporting the Department of Defense's diverse and specialized pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DU26FEMNZ?
SPE2DU26FEMNZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DU26FEMNZ worth?
The government has obligated $2,052 on SPE2DU26FEMNZ.
Is contract SPE2DU26FEMNZ an order under another contract?
Yes. SPE2DU26FEMNZ is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMNZ competed?
The extent of competition for SPE2DU26FEMNZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award